Back to Search
Start Over
The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
- Source :
-
Trends in Immunology . Nov2020, Vol. 41 Issue 11, p965-967. 3p. - Publication Year :
- 2020
-
Abstract
- The current pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 is a significant global health challenge. A recent study by Carvelli and colleagues now demonstrates the involvement of complement C5a and its receptor C5aR1 in disease progression and suggests that blockade of the C5a-C5aR1 axis may represent a potential therapeutic strategy against COVID-19. [ABSTRACT FROM AUTHOR]
- Subjects :
- *COVID-19
*COMPLEMENT receptors
*SARS-CoV-2
*THERAPEUTICS
*DISEASE progression
Subjects
Details
- Language :
- English
- ISSN :
- 14714906
- Volume :
- 41
- Issue :
- 11
- Database :
- Academic Search Index
- Journal :
- Trends in Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 146614700
- Full Text :
- https://doi.org/10.1016/j.it.2020.09.008